PT2069395E - Novos antigénios e anticorpos associados a adenocarcinoma ductal do pâncreas - Google Patents

Novos antigénios e anticorpos associados a adenocarcinoma ductal do pâncreas Download PDF

Info

Publication number
PT2069395E
PT2069395E PT07820692T PT07820692T PT2069395E PT 2069395 E PT2069395 E PT 2069395E PT 07820692 T PT07820692 T PT 07820692T PT 07820692 T PT07820692 T PT 07820692T PT 2069395 E PT2069395 E PT 2069395E
Authority
PT
Portugal
Prior art keywords
pda
antibodies
enoa
isoforms
ala
Prior art date
Application number
PT07820692T
Other languages
English (en)
Portuguese (pt)
Inventor
Francesco Novelli
Barbara Tomaino
Paola Cappello
Original Assignee
Ribovax Biotechnologies Sa
Bioline Diagnostici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa, Bioline Diagnostici Srl filed Critical Ribovax Biotechnologies Sa
Publication of PT2069395E publication Critical patent/PT2069395E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT07820692T 2006-09-29 2007-09-28 Novos antigénios e anticorpos associados a adenocarcinoma ductal do pâncreas PT2069395E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121552 2006-09-29
EP06126726 2006-12-20

Publications (1)

Publication Number Publication Date
PT2069395E true PT2069395E (pt) 2012-04-27

Family

ID=38895810

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07820692T PT2069395E (pt) 2006-09-29 2007-09-28 Novos antigénios e anticorpos associados a adenocarcinoma ductal do pâncreas

Country Status (18)

Country Link
US (1) US8071721B2 (enExample)
EP (1) EP2069395B1 (enExample)
JP (1) JP2010505104A (enExample)
KR (1) KR20090094227A (enExample)
CN (1) CN101578295B (enExample)
AT (1) ATE542831T1 (enExample)
AU (1) AU2007301966B2 (enExample)
BR (1) BRPI0717282A2 (enExample)
CA (1) CA2664841A1 (enExample)
DK (1) DK2069395T3 (enExample)
EA (1) EA016731B1 (enExample)
ES (1) ES2381304T3 (enExample)
IL (2) IL197868A (enExample)
NO (1) NO20091662L (enExample)
NZ (1) NZ576409A (enExample)
PL (1) PL2069395T3 (enExample)
PT (1) PT2069395E (enExample)
WO (1) WO2008037792A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171569A (zh) * 2008-05-09 2011-08-31 杜克大学 检测和治疗癌症的自身抗体
IT1398782B1 (it) 2009-09-11 2013-03-18 Novelli Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi.
ITTO20120523A1 (it) * 2012-06-15 2013-12-16 Natimab Therapeutics S R L Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico
CA2949045C (en) * 2013-12-20 2022-07-05 Development Center For Biotechnology Alpha-enolase specific antibodies and methods of uses in cancer therapy
EP3094341B1 (en) 2014-01-13 2019-10-02 Berg LLC Enolase 1 (eno1) compositions and uses thereof
CN115786317B (zh) * 2022-12-12 2026-03-20 江苏三联生物工程股份有限公司 重组神经元特异性烯醇化酶及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay

Also Published As

Publication number Publication date
AU2007301966A1 (en) 2008-04-03
EA200970332A1 (ru) 2009-10-30
EP2069395B1 (en) 2012-01-25
US20100028907A1 (en) 2010-02-04
JP2010505104A (ja) 2010-02-18
AU2007301966B2 (en) 2013-02-21
IL197868A (en) 2013-03-24
PL2069395T3 (pl) 2012-06-29
EA016731B1 (ru) 2012-07-30
DK2069395T3 (da) 2012-05-14
WO2008037792A1 (en) 2008-04-03
CN101578295B (zh) 2013-02-27
ES2381304T3 (es) 2012-05-25
US8071721B2 (en) 2011-12-06
IL218442A0 (en) 2012-04-30
NZ576409A (en) 2012-02-24
CA2664841A1 (en) 2008-04-03
EP2069395A1 (en) 2009-06-17
BRPI0717282A2 (pt) 2013-10-15
ATE542831T1 (de) 2012-02-15
IL197868A0 (en) 2011-08-01
NO20091662L (no) 2009-06-29
CN101578295A (zh) 2009-11-11
KR20090094227A (ko) 2009-09-04

Similar Documents

Publication Publication Date Title
Sarrats et al. Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis
Suárez et al. CD9 inhibition reveals a functional connection of extracellular vesicle secretion with mitophagy in melanoma cells
Gomes et al. Glycoproteomic analysis of serum from patients with gastric precancerous lesions
Claverol et al. Mapping and structural dissection of human 20 S proteasome using proteomic approaches
Zhao et al. Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma
Chu et al. Mapping Post-translational Modifications of the Histone Variant MacroH2A1 Using Tandem Mass Spectrometry* S
Vercoutter‐Edouart et al. Glycoproteomics and glycomics investigation of membrane N‐glycosylproteins from human colon carcinoma cells
PT2069395E (pt) Novos antigénios e anticorpos associados a adenocarcinoma ductal do pâncreas
Zheng et al. PA28β regulates cell invasion of gastric cancer via modulating the expression of chloride intracellular channel 1
Wang et al. An autoantigen atlas from human lung HFL1 cells offers clues to neurological and diverse autoimmune manifestations of COVID-19
He et al. Phosphatidylethanolamine binding protein 4 (PEBP4) is a secreted protein and has multiple functions
Caballero et al. Chicken GRIFIN: a homodimeric member of the galectin network with canonical properties and a unique expression profile
Zhong et al. Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS
EP3042203B1 (en) Biomarkers for cholangiocellular carcinoma (ccc)
Kischel et al. Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells
Semaan et al. Identification of potential glycoprotein biomarkers in estrogen receptor positive (ER+) and negative (ER-) human breast cancer tissues by LC-LTQ/FT-ICR mass spectrometry
Afshari et al. Glycoproteoforms of osteoarthritis-associated lubricin in plasma and synovial fluid
Hazari et al. The endoplasmic reticulum stress sensor IRE1 regulates collagen secretion through the enforcement of the proteostasis factor P4HB/PDIA1 contributing to liver damage and fibrosis
Arielly et al. Quantitative analysis of caveolin-rich lipid raft proteins from primary and metastatic colorectal cancer clones
Mackay et al. Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
Ye et al. Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics
de Albuquerque Vasconcelos et al. Comparing the Immunoexpression of FUT3 and FUT6 between prostatic adenocarcinoma and benign prostatic hyperplasia
Hintze et al. The ligand preference of LRP1 is regulated by O-glycans
Cho et al. Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells
San Francisco et al. Role of proteomics in the study of Trypanosoma cruzi biology